Focusing on the frontiers of innovation and jointly building an industrial ecosystem | Building on the signals from the BioBAY industry event, HjClean explores new pathways for cleanroom compliance in

The 2026 High-quality Development Expo for Innovative Drugs and Medical Devices, hosted by Suzhou Industrial Park Biotech Development Co., Ltd.

Focusing on the frontiers of innovation and jointly building an industrial ecosystem | Building on the signals from the BioBAY industry event, HjClean explores new pathways for cleanroom compliance in

The 2026 High-quality Development Expo for Innovative Drugs and Medical Devices, hosted by Suzhou Industrial Park Biotech Development Co., Ltd. (BioBAY), concluded successfully at the Suzhou International Expo Center from November 13 to 15, 2026. Centered on the theme of “Explore Innovation Frontiers, Shape Industry Ecosystems”, the expo served as a communication platform covering the entire biopharmaceutical industrial chain.

It featured more than 20 parallel sub-forums for in-depth discussions on core industry topics including innovative drug R&D, CGT (cell and gene therapy), ADCs, GMP compliance development, domestic supply chain upgrading, and commercialization of new medicines.

The event brought together innovative pharmaceutical enterprises, CXOs, medical device manufacturers, research institutes and investment institutions, injecting new momentum into Suzhou as a leading biopharmaceutical hub.The grand expo outlined directions for the industrialization, compliance and localization of cutting-edge sectors, charting a path for technological advancement among supporting suppliers in the biopharmaceutical industry. Rooted in Suzhou and a high-tech enterprise specializing in aseptic cleanroom solutions for biopharmaceuticals, Suzhou HJClean Technology Co., Ltd. aligns with the industrial trends highlighted at the expo and keeps refining integrated cleanroom solutions tailored for the innovative drug and medical device sector.With the rapid growth of innovative drugs, cell therapies and high-potency pharmaceuticals, regulatory requirements have become increasingly stringent for containment protection of aseptic production environments, environmental monitoring, sterilization validation and data integrity. Stable and compliant cleanroom and containment systems constitute core support for translating innovations from laboratories into industrial production. HJClean’s product portfolio includes aseptic isolator, cell processing isolator,VHP pass box,Vaporized hydrogen peroxide sterilizer, online particle counter monitoring system, airborne particle counter, BIBO (bag-in/bag-out) filters, negative-pressure dispensing booth and clean laminar flow hood. The company also provides turnkey services covering design, construction and validation of cleanroom facilities. These offerings are suitable for CGT preparation laboratories, pilot and commercial production lines for sterile preparations, sterility testing, and containment of HPAPI, fully complying with GMP requirements.

HJClean is a member unit of the China Cleanroom Standards Committee and runs the Jiangsu Provincial Engineering Technology Research Center. It delivers full-spectrum capabilities ranging from solution design, in-house R&D and manufacturing of equipment to on-site validation and ongoing operation & maintenance. Serving innovative pharmaceutical firms, CDMOs and medical device manufacturers for years, the company continuously promotes localization and intelligent upgrading of cleanroom equipment, helping clients mitigate compliance risks and accelerate project implementation.

The company will keep track of process and compliance requirements in cutting-edge segments such as CGT, ADCs and sterile preparations. It will advance core technologies for containment isolation, online environmental monitoring and vaporized hydrogen peroxide sterilization, and develop customized cleanroom solutions for advanced drugs and medical devices.

By actively collaborating with BioBAY and upstream and downstream partners across the industrial chain, HJClean will help consolidate the biopharmaceutical supply chain and support the high-quality and sustainable development of China’s innovative drug and medical device industry.